4 completed, 1 recruiting, 1 terminated, 1 unknown. 7 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 4, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 1 | 3 | Completed 2, Recruiting 1 |
Follow Radioembolization: new trials by email Literature Review of Radioembolization trials Research Report on Radioembolization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial Angiogram, Biospecimen Collection, Computed Tomography - Stage I Renal Cell Cancer, Stage II Renal Cell Cancer | Phase 1 / Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 25 | 2024-12-26 | 2026-08-21 |
| Radioembolization in Elderly/ Fragile Patients With mCRC radioembolization, Standard of care first-line systemic therapy - Colorectal Cancer Metastatic | Phase 2 | Terminated | UMC Utrecht | 18 | 2022-06-01 | 2026-05-14 |
| Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCC Durvalumab, Radioembolization - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Completed | Seoul National University Hospital | 24 | 2020-06-12 | 2023-03-16 |
| Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets FOLFOX7 (Folinic acid, 5-Fluorouracil, and Oxaliplatin), TheraSpheres - Liver Cancer, Pancreatic Cancer | Phase 2 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 9 | 2012-04-01 | 2017-03-03 |
| Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC) doxorubicin, superabsorbent polymer microspheres, embolotherapy - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Completed | University of British Columbia | 24 | 2010-01-01 | 2014-03-17 |
| Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery yttrium Y 90 glass microspheres, Doxorubicin - Liver Cancer | Phase 2 | Completed | Northwestern University | 45 | 2009-08-01 | 2022-11-21 |
| Definitive Therapy for Oligometastatic Solid Malignancies Complete Surgical Removal, Stereotactic Radiosurgery, Ablative external beam radiation dose - Stage IV or Recurrent Carcinoma or Sarcoma | Phase 2 | Unknown | Rocky Mountain Cancer Centers | 110 | 2005-12-01 | 2013-07-15 |
Carcinoma, Hepatocellular (3) · Liver Neoplasms (2) · Carcinoma, Renal Cell (1) · Neoplasm Metastasis (1) · Pancreatic Neoplasms (1) · Recurrence (1) · Sarcoma (1)
H. Lee Moffitt Cancer Center and Research Institute (1) · Jonsson Comprehensive Cancer Center (1) · Northwestern University (1) · Rocky Mountain Cancer Centers (1) · Seoul National University Hospital (1) · UMC Utrecht (1) · University of British Columbia (1)
United States (4) · Canada (1) · Netherlands (1) · South Korea (1)
Alan Weiss, MD (1) · Charles Scudamore, MD (1) · David Owen, MD (1) · Dennise Carter, MD (1) · Ellen Wasan, PhD (1) · Eric Yoshida, MD (1) · Jo-Ann Ford, RN (1) · Riad Salem, MD (1) · Sarah Hoffe, M.D. (1) · Sharlene Gill, MD (1) · Siddharth A Padia (1) · Sigfried Erb, MD (1) · Stephen Chung, MD (1) · Stephen Ho, MD (1) · Yoon Jun Kim, MD. PhD (1)
PMID 24982375, PMID 27575820, PMID 41276366
P30CA060553 (1)